Davis Selected Advisers’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $879M | Sell |
12,239,666
-520,845
| -4% | -$40.1M | 4.04% | 8 |
|
|
2025
Q4 | $1.01B | Buy |
12,760,511
+1,356,870
| +12% | +$107M | 4.55% | 5 |
|
|
2025
Q3 | $860M | Sell |
11,403,641
-183,149
| -2% | -$12.6M | 4.49% | 5 |
|
|
2025
Q2 | $799M | Buy |
11,586,790
+37,733
| +0.3% | +$2.47M | 4.27% | 6 |
|
|
2025
Q1 | $782M | Buy |
11,549,057
+163,107
| +1% | +$9.76M | 4.51% | 4 |
|
|
2024
Q4 | $511M | Buy |
11,385,950
+11,018,438
| +2,998% | +$618M | 2.97% | 13 |
|
|
2024
Q3 | $23.1M | Buy |
367,512
+2,730
| +0.7% | +$159K | 0.13% | 53 |
|
|
2024
Q2 | $21.5M | Buy |
364,782
+192,039
| +111% | +$12M | 0.13% | 51 |
|
|
2024
Q1 | $13.8M | Sell |
172,743
-33,671
| -16% | -$2.57M | 0.08% | 61 |
|
|
2023
Q4 | $16.3M | Buy |
206,414
+1,782
| +0.9% | +$127K | 0.09% | 60 |
|
|
2023
Q3 | $14.3M | Sell |
204,632
-3,177
| -2% | -$225K | 0.09% | 59 |
|
|
2023
Q2 | $14.4M | Sell |
207,809
-137
| -0.1% | -$9.75K | 0.09% | 64 |
|
|
2023
Q1 | $15.5M | Sell |
207,946
-144
| -0.1% | -$12.1K | 0.1% | 60 |
|
|
2022
Q4 | $19.4M | Buy |
208,090
+722
| +0.3% | +$69.7K | 0.13% | 50 |
|
|
2022
Q3 | $19.8M | Sell |
207,368
-904
| -0.4% | -$89.5K | 0.14% | 48 |
|
|
2022
Q2 | $19.3M | Sell |
208,272
-152
| -0.1% | -$14.8K | 0.12% | 52 |
|
|
2022
Q1 | $21.1M | Sell |
208,424
-5,309
| -2% | -$558K | 0.11% | 56 |
|
|
2021
Q4 | $22M | Sell |
213,733
-565,467
| -73% | -$52.3M | 0.1% | 62 |
|
|
2021
Q3 | $66.1M | Sell |
779,200
-1,226
| -0.2% | -$103K | 0.31% | 40 |
|
|
2021
Q2 | $65.1M | Sell |
780,426
-853
| -0.1% | -$69.9K | 0.27% | 46 |
|
|
2021
Q1 | $58.8M | Sell |
781,279
-10,120
| -1% | -$737K | 0.26% | 43 |
|
|
2020
Q4 | $54.1M | Sell |
791,399
-6,796
| -0.9% | -$442K | 0.26% | 38 |
|
|
2020
Q3 | $46.6M | Sell |
798,195
-14,422
| -2% | -$897K | 0.26% | 39 |
|
|
2020
Q2 | $52.8M | Buy |
812,617
+7,998
| +1% | +$504K | 0.31% | 35 |
|
|
2020
Q1 | $47.7M | Sell |
804,619
-7,689
| -0.9% | -$513K | 0.32% | 37 |
|
|
2019
Q4 | $60.3M | Sell |
812,308
-253,227
| -24% | -$17.8M | 0.29% | 37 |
|
|
2019
Q3 | $67.2M | Sell |
1,065,535
-36,147
| -3% | -$2.14M | 0.34% | 35 |
|
|
2019
Q2 | $60M | Sell |
1,101,682
-22,557
| -2% | -$1.21M | 0.3% | 35 |
|
|
2019
Q1 | $60.6M | Sell |
1,124,239
-5,820
| -0.5% | -$359K | 0.3% | 37 |
|
|
2018
Q4 | $74M | Buy |
+1,130,059
| New | +$84.4M | 0.41% | 33 |
|
|
2014
Q4 | – | Sell |
-2,153,905
| Closed | -$171M | – | 194 |
|
|
2014
Q3 | $171M | Sell |
2,153,905
-6,858,246
| -76% | -$541M | 0.53% | 44 |
|
|
2014
Q2 | $679M | Sell |
9,012,151
-2,423,108
| -21% | -$183M | 2.02% | 15 |
|
|
2014
Q1 | $856M | Sell |
11,435,259
-21,623,270
| -65% | -$1.53B | 2.36% | 11 |
|
|
2013
Q4 | $2.37B | Sell |
33,058,529
-3,389,529
| -9% | -$218M | 5.78% | 5 |
|
|
2013
Q3 | $2.07B | Sell |
36,448,058
-2,448,543
| -6% | -$146M | 5.37% | 5 |
|
|
2013
Q2 | $2.22B | Buy |
+38,896,601
| New | +$2.25B | 5.65% | 5 |
|
Other funds holding CVS
VCM
VPM
Davis Selected Advisers's CVS Position: Q1 2026 in Review
Davis Selected Advisers reduced its CVS Health (CVS) stake by 4.1% in Q1 2026, selling an estimated $40.1M and leaving 12,239,666 shares worth $879M. The position accounts for 4.04% of the portfolio, ranked #8.
Davis Selected Advisers first reported a position in CVS in Q2 2013 and has held it in 36 quarters since. The position peaked at $2.37B in Q4 2013. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Davis Selected Advisers held 12,239,666 shares of CVS Health worth $879M as of Q1 2026.
- Davis Selected Advisers sold 520,845 CVS Health shares in Q1 2026, an estimated $40.1M.
- CVS Health made up 4.04% of Davis Selected Advisers's portfolio in Q1 2026, its #8 holding.
- Davis Selected Advisers first reported a position in CVS Health in Q2 2013 and has held it in 36 quarters since.
- Davis Selected Advisers's CVS Health position peaked at $2.37B in Q4 2013.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Davis Selected Advisers's 13F filing for Q1 2026, filed 7 May 2026.